Legislature(2017 - 2018)GRUENBERG 120
02/28/2017 10:00 AM House FISHERIES
Note: the audio
and video
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| HJR12 | |
| HB107 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| *+ | HJR 12 | TELECONFERENCED | |
| *+ | HB 107 | TELECONFERENCED | |
| + | TELECONFERENCED |
HJR 12-OPPOSING GEN ENGINEERED SALMON
10:03:32 AM
CHAIR STUTES announced that the first order of business would be
HOUSE JOINT RESOLUTION NO. 12, Opposing the United States Food
and Drug Administration's approval of AquaBounty AquAdvantage
genetically engineered salmon; and urging the United States
Congress to enact legislation that requires prominently labeling
genetically engineered products with the words "Genetically
Modified" on the product's packaging.
10:03:47 AM
REPRESENTATIVE TARR, as prime sponsor of HJR 12, began by saying
the proposed resolution would support efforts by Alaska U.S.
Senator Lisa Murkowski at the federal level. She began a
PowerPoint presentation and referred to Slide 2, entitled "Why
the need for HJR 12?" She stated that in November 2015, the
U.S. Food and Drug Administration (FDA) allowed genetically
modified (GM) salmon, which is the first time a GM animal has
been approved for human consumption. She expressed that she is
strongly opposed to this. The approval process used by the FDA
was the "veterinary drug" approval process. She maintained that
since the product is for human consumption, it is questionable
whether the veterinary drug approval process is the appropriate
process for considering this use of technology. She mentioned
that traditionally a different regulatory route would have been
utilized.
10:03:59 AM
REPRESENTATIVE TARR turned to Slide 3, entitled "What is GM
salmon?" She explained that the GM salmon approved by the FDA
is produced by adding the deoxyribonucleic acid (DNA) from two
different species of fish to Atlantic salmon. She identified
the two fish as follows: the ocean pout, shown on the left side
of the slide, is an eel-like fish that offers continuous growth
due to its natural life cycle; and the Chinook salmon, shown on
the right, is selected for its size. Consequently, the GM fish
grows bigger and faster.
REPRESENTATIVE TARR turned to Slide 4, entitled "How does it
work?" to illustrate the different growth rates. The goal is to
produce a salmon that grows to full size twice as fast.
REPRESENTATIVE TARR moved on to Slide 5, entitled "Why GM
Salmon?" She cited statements on the website of the company who
proposed GM salmon, AquaBounty, to point out that the actions of
the company were "never really about sustainability; this has
always just been about profit." She relayed the information on
the website, which read [original punctuation provided]: "The
innovative faster growing AquAdvantage Salmon, which would
shorten production cycles by half and drastically reduce feed
costs, could finally make land-based fish farming economically
viable." She commented that "we have to question ... the
difference between what's healthy for an ecosystem versus what
is an economic opportunity."
10:06:47 AM
REPRESENTATIVE TARR referred to Slides 6 and 7 to illustrate
Alaskan salmon. She moved on to Slide 8, which portrays the
production environment of GM salmon: it is grown in an
industrial warehouse setting with land-based pens. She stated
that the proposal from AquAdvantage includes making the GM
salmon fish eggs on Prince Edward Island (PEI) in Canada;
growing them to size in Panama; and shipping the fish back to
the U.S. for market. She asserted that three different
countries are involved because of opposition [to GM salmon] from
other countries and the United States.
REPRESENTATIVE TARR referred to Slide 9, entitled "Concerns
about GM salmon," and listed the concerns: threats to wild
salmon, risks to human health, and risk to the state economy.
She turned to Slide 10, entitled "Threat to Wild Salmon," and
relayed that escapement is always an issue. She mentioned that
the Alaska Department of Fish & Game (ADF&G) solicits reports
from fisherman who have caught farmed salmon, and she added
there have been many such reports.
REPRESENTATIVE TARR referred to the map on Slide 11. She
relayed that she was invited by residents of PEI to the site
where the AquaBounty eggs would be produced; the residents were
concerned about the negative effects of being known as the home
of the "Frankenfish." She said the AquaBounty site was on the
bay leading to the St. Lawrence Seaway and on to the Atlantic
Ocean. She maintained that there are concerns about escapement
at that location, because of its proximity to a water body.
REPRESENTATIVE TARR turned to Slide 12 showing photographs of
her visit: the AquaBounty facility, which appears to be low
technology ("low-tech"); meeting with the Premier of PEI to ask
his opinion of the proposal; and local residents who have
expressed opposition to the proposal.
10:09:36 AM
REPRESENTATIVE TARR moved on to Slide 13, entitled "Threat to
Wild Salmon," and relayed the threats: GM salmon can spread
disease; GM salmon are more aggressive and can outcompete wild
salmon; and GM salmon can cross breed with wild fish. She
continued with Slide 14, which displayed screenshots of several
articles on the results of scientific studies on GM salmon. She
referred to the headline, "GM salmon can breed with trout and
harm ecosystem," and explained that scientists learned that GM
salmon can breed with trout, and the new fish which results can
outcompete both the GM salmon and the wild relative. She added
that the new, more aggressive fish could be very damaging to
natural ecosystems.
REPRESENTATIVE TARR continued with Slide 15, entitled "Risks to
Human Health." She mentioned that no long-term studies have
been conducted on the safety of human consumption of GM salmon.
Since the FDA used the veterinary drug approval process, it was
not necessary for it to consider the safety of human
consumption.
REPRESENTATIVE TARR referred to Slide 16, entitled "Risk to
State's Economy," and reminded the committee of the dramatic
drop in the price of Alaskan wild salmon when farmed salmon came
onto the market. The state responded by creating the
Alaska Seafood Marketing Institute (ASMI) and investing
tremendously in branding Alaska's wild salmon. She stated that
the state's marketing efforts have been very successful; Alaska
wild salmon is a widely recognized brand; and people consider
Alaska wild salmon to be a healthy source of protein. She
declared, "That creates a lot of value." She added that another
economic risk is the risk to Alaskan jobs, since the seafood
industry is the largest private sector employer with over 70,000
jobs.
10:11:56 AM
REPRESENTATIVE TARR stated that Alaskans are not alone in
opposing GM salmon and named the various sources of opposition
listed on Slide 17: Alaska's congressional delegation oppose GM
salmon; Senator Murkowski has been a leader and will be
introducing additional legislation on this matter; more than 40
members of the U.S. Congress oppose GM salmon; more than 1.5
million comments opposing GM salmon were received by the FDA in
the comment period; more than 90 percent of Americans support
labeling of GM foods reflecting greater public interest in the
source and healthfulness of food; and 65 retailers, many of them
major, will not sell GM salmon.
REPRESENTATIVE TARR referred to Slide 18, "International
Opposition," to report that there have been lawsuits regarding
GM salmon; there is concern for the damage to wild salmon
populations on the East Coast of the U.S.; and there have been
dam removal projects on the West Coast of the U.S. to restore
traditional fish passage areas. She concluded that people are
working hard to support and sustain wild salmon populations.
10:14:01 AM
The committee took a brief at-ease at 10:14 a.m.
10:14:26 AM
REPRESENTATIVE TARR referred to Slide 19, entitled "US Lawsuit
filed March 31." She mentioned the various groups and efforts
opposing GM foods and imposing regulations, especially on the
West Coast: legislators; Pacific NorthWest Economic Region
(PNWER); ballot initiatives in Canada, Washington, and Oregon;
and local ordinances opposing GM foods. She relayed that a
lawsuit was filed in the United States in March 2016; the
lawsuit went to court on Election Day last year; and no
judgement has been issued yet. The lawsuit claims the approval
process was not adequate in considering GM salmon a food source
for humans, and there are unanswered questions about ecological
impacts. She asserted that since salmon is so important to
Alaska - to its culture, its tradition, its communities, and to
the health of Alaskans - "we should stand together as we have in
the past and say 'No' and stand together in opposition of GM
salmon."
10:16:00 AM
REPRESENTATIVE CHENAULT asked if HJR 12 addresses only GM fish
and no other products.
REPRESENTATIVE TARR replied, "Yes, that is correct."
REPRESENTATIVE CHENAULT relayed that the proposed resolution
states that more than two million Americans are opposed to the
FDA approval [of GM salmon]. He mentioned that Representative
Tarr testified that about 1.5 million people had submitted
testimony during the FDA comment period.
REPRESENTATIVE TARR explained that one of the numbers reflects
the individual comments received, and a single comment may
represent many signatures on a petition.
REPRESENTATIVE CHENAULT asked for confirmation of his
understanding of the GM salmon production process: the eggs are
incubated on PEI, then moved to Panama for rearing.
REPRESENTATIVE TARR answered, "That is the proposal that's been
approved. It requires the three countries' involvement: the
eggs in one location; the growing the fish in Panama; and then,
for sale in the United States."
10:18:02 AM
REPRESENTATIVE CHENAULT asked for more clarification regarding
the danger a [fish] egg poses. He mentioned that the discussion
has addressed concern for the eggs growing into bigger fish and
destroying what is left of the [wild] Atlantic salmon. He said
eggs are not usually released into the wild and grown, thus he
questioned the concern about the facility being on PEI, the
movement of eggs to Panama, and the shipment of the fish back to
the U.S.
REPRESENTATIVE TARR replied that the concern is that the process
includes early stage development, and there is opposition to
interbreeding with wild [salmon] populations. She maintained
that there is concern that Panama environmental standards would
not be the same as those in the U.S. She asked, "Is the
likelihood of escapement low?" She attested that it probably is
low because of the [prevention] measures put in place. She said
she didn't want to suggest negligence on the part of Panama;
however, she maintained that the threat is real. She stated
that the McGill [University] study that she referred to on Slide
14 [Oke KB, Westley PAH, Moreau DTR, Fleming IA. 2013
Hybridization between genetically modified Atlantic salmon and
wild brown trout reveal novel ecological interactions. Proc.
Royal Society B] was published just after the closing of the
comment period for the proposal. She relayed that she wrote to
the FDA asking that it consider this recent research report.
She asserted that the dynamic of the conversation on the
proposal changed once there was research showing that
interbreeding occurred, and that interbreeding was problematic.
10:20:14 AM
REPRESENTATIVE EASTMAN asked if the sponsor would consider
adding "salmon" after the word "engineered" on line 3, page 1,
of the resolution. He stated that the resulting phrase would
read, "urging the United States Congress to enact legislation
that requires prominently labeling genetically engineered salmon
products". He maintained that "GM products" is difficult to
define; if the resolution was limited to salmon, it may receive
more support.
REPRESENTATIVE TARR responded that is a great suggestion, which
had been considered. She explained that the proposed resolution
reflects the broader labeling legislation efforts by Congress;
however, since the intent of Alaska's resolution is to be
specific to salmon, she said she did not have a problem with
limiting the resolution to salmon.
REPRESENTATIVE EASTMAN asked for more information about what
happens if a fertilized salmon egg escapes the PEI facility:
Would the salmon egg grow naturally and result in a salmon or
would that be less likely due to the genetic engineering?
REPRESENTATIVE TARR responded that the way the proposal is
written, it is specific to certain life stages, and that is what
has been approved by the FDA. She added that the PEI facility
has more than just the eggs that will be used for the GM fish,
which is the concern of the local residents. She stated that
AquaBounty has proposals for several other species. She
maintained that there is a lack of confidence in their work, and
the people she contacted want to take every precautionary
measure.
10:23:52 AM
REPRESENTATIVE EASTMAN opined that based on the public concern
for the proposal, placing the facility near a water body was
particularly unreceptive to that concern. He maintained that
there are more appropriate locations.
REPRESENTATIVE TARR said that she totally agrees with
Representative Eastman. She stated that AquaBounty was at one
time based in Massachusetts and wanted to locate the facility in
that state. She relayed that the local community refused, which
lead to the company changing locations. She opined that having
three countries involved in the production of a product makes
regulation more challenging and the public less comfortable with
the process.
10:25:03 AM
REPRESENTATIVE EASTMAN moved to adopt Conceptual Amendment 1,
which would be to limit the proposed resolution to GM salmon.
He opined that due to the many definitions of "genetically
engineered," it would be subject to additional criticism.
10:25:23 AM
CHAIR STUTES objected for the purpose of discussion.
REPRESENTATIVE TARR declared that she is not opposed to the
offered conceptual amendment. She suggested that the proposed
resolution specify "genetically engineered salmon or salmon
products".
REPRESENTATIVE EASTMAN said he concurred with Representative
Tarr's suggestion.
10:25:50 AM
CHAIR STUTES removed her objection to Conceptual Amendment 1,
[as amended]. There being no further objection, Conceptual
Amendment 1, as amended, was adopted.
10:26:02 AM
REPRESENTATIVE CHENAULT clarified that the committee's action
was the adoption of Representative Eastman's conceptual
amendment, as amended by Representative Tarr's addition of
"salmon or salmon products".
10:26:24 AM
CHAIR STUTES opened public testimony on HJR 12. After
ascertaining that there was no one who wished to testify, she
closed public testimony.
10:26:44 AM
REPRESENTATIVE KREISS-TOMKINS expressed his appreciation of the
action and advocacy on the issue addressed by HJR 12.
10:27:29 AM
REPRESENTATIVE FANSLER moved to report HJR 12, as amended, out
of committee with individual recommendations and the
accompanying fiscal notes. There being no objection, CSHJR
12(FSH) was reported from the House Special Committee on
Fisheries.
| Document Name | Date/Time | Subjects |
|---|---|---|
| HJR012 Sponsor Statement 2.22.17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 3/13/2017 1:00:00 PM HRES 3/14/2017 3:00:00 PM HRES 3/15/2017 1:00:00 PM HRES 3/20/2017 7:00:00 PM HRES 3/22/2017 6:00:00 PM |
HJR 12 |
| HJR012 ver A 2.22.17.PDF |
HFSH 2/28/2017 10:00:00 AM HRES 3/13/2017 1:00:00 PM HRES 3/14/2017 3:00:00 PM HRES 3/15/2017 1:00:00 PM HRES 3/20/2017 7:00:00 PM HRES 3/22/2017 6:00:00 PM |
HJR 12 |
| HJR012 Fiscal Note LEG-SESS-02-23-17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 3/13/2017 1:00:00 PM HRES 3/14/2017 3:00:00 PM HRES 3/20/2017 7:00:00 PM HRES 3/22/2017 6:00:00 PM |
HJR 12 |
| HJR012 Support - Alaska Trollers Association 2.27.17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 3/13/2017 1:00:00 PM HRES 3/14/2017 3:00:00 PM HRES 3/15/2017 1:00:00 PM HRES 3/20/2017 7:00:00 PM HRES 3/22/2017 6:00:00 PM |
HJR 12 |
| HJR012 Support - Southeast Alaska Fishermen's Alliance 2.27.17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 3/13/2017 1:00:00 PM HRES 3/14/2017 3:00:00 PM HRES 3/15/2017 1:00:00 PM HRES 3/20/2017 7:00:00 PM HRES 3/22/2017 6:00:00 PM |
HJR 12 |
| HJR012 Support - Petersburg Vessel Owners Association 2.27.17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 3/13/2017 1:00:00 PM HRES 3/14/2017 3:00:00 PM HRES 3/15/2017 1:00:00 PM HRES 3/20/2017 7:00:00 PM HRES 3/22/2017 6:00:00 PM |
HJR 12 |
| HJR012 Support - Southeast Alaska Seiners Association 2.27.17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 3/13/2017 1:00:00 PM HRES 3/14/2017 3:00:00 PM HRES 3/15/2017 1:00:00 PM HRES 3/20/2017 7:00:00 PM HRES 3/22/2017 6:00:00 PM |
HJR 12 |
| HJR012 Support - United Fishermen of Alaska.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 3/14/2017 3:00:00 PM HRES 3/15/2017 1:00:00 PM HRES 3/20/2017 7:00:00 PM HRES 3/22/2017 6:00:00 PM |
HJR 12 |
| HJR012 Support - United Southeast Alaska Gillnetters 2.27.17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 3/13/2017 1:00:00 PM HRES 3/14/2017 3:00:00 PM HRES 3/15/2017 1:00:00 PM HRES 3/20/2017 7:00:00 PM HRES 3/22/2017 6:00:00 PM |
HJR 12 |
| HJR012 Supporting Document-Alaska Dispatch News Article 2.22.17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 3/13/2017 1:00:00 PM HRES 3/14/2017 3:00:00 PM HRES 3/15/2017 1:00:00 PM HRES 3/20/2017 7:00:00 PM HRES 3/22/2017 6:00:00 PM |
HJR 12 |
| HJR012 Supporting Document-Reps. Young and Defazio 2.22.17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 3/13/2017 1:00:00 PM HRES 3/14/2017 3:00:00 PM HRES 3/15/2017 1:00:00 PM HRES 3/20/2017 7:00:00 PM HRES 3/22/2017 6:00:00 PM |
HJR 12 |
| HJR012 Supporting Document-Sen. Murkowski 2.22.17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 3/13/2017 1:00:00 PM HRES 3/14/2017 3:00:00 PM HRES 3/15/2017 1:00:00 PM HRES 3/20/2017 7:00:00 PM |
HJR 12 |
| HB107 Sponsor Statement 2.8.17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Sectional Analysis 2.8.2017.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
|
| HB107 Ver O.PDF |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Fiscal Note DFG-DCF-02-24-17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Additional Documentation. Considerations for Salmon Restoration Planning.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Additional Documents, Josephson Permitting process letter.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Additional Documentation. Egg Survival Rate Comparrison.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Gulkana Incubation Picture.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Moist air incubator picture.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Support ADN Article.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Support Copper Valley Chamber of Commerce.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Support Doyon 2.14.17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Support Mentasta Council.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Support Nenana City School District 2.16.17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Support Pete Velsko.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 4/26/2017 1:00:00 PM |
HB 107 |
| HB107 Sectional Analysis 2.8.2017.pdf |
HFSH 2/28/2017 10:00:00 AM |
HB 107 |
| HJR012 Support UFA.pdf |
HFSH 2/28/2017 10:00:00 AM |
HJR 12 |
| HJR012 Supporting Document - Presentation House Resources Committee 3.12.17.pdf |
HFSH 2/28/2017 10:00:00 AM HRES 3/13/2017 1:00:00 PM HRES 3/14/2017 3:00:00 PM HRES 3/15/2017 1:00:00 PM HRES 3/20/2017 7:00:00 PM HRES 3/22/2017 6:00:00 PM |
HJR 12 |